Pfizer smashes expectations — but can it keep going as Trump eyes 250% tariffs on drugs and semiconductors?

Hosted by Michelle Martin with Ryan Huang, this Market View dives into what’s powering Pfizer’s rebound, whether Yum! Brands is giving us clues about US consumer strength, and how new Trump tariffs may rattle markets.

Plus: Tesla vs BYD, TSMC resilience, CICT’s billion-dollar REIT deal, and a check on Singapore’s STI after breaking 4,200.

Catch all the moves — and what they could mean for your portfolio.